ACER Acer Therapeutics Inc.

2.09
+0.14  (+7%)
Previous Close 1.95
Open 1.99
Price To Book 0.77
Market Cap 21,098,918
Shares 10,095,176
Volume 481,895
Short Ratio
Av. Daily Volume 397,204

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

CRL issued June 25, 2019.
EDSIVO
Vascular Ehlers-Danlos Syndrome
Phase 2b trial did not meet primary endpoint - October 28, 2016.
Tovaxin (Tcelna)
Secondary Progressive MS (SPMS)
Pivotal bridging trial to be initiated 4Q 2019 with NDA filing mid-2020.
ACER-001
Urea cycle disorder (UCD)
Phase 1/2 trial to be initiated mid-2020.
Osanetant
induced Vasomotor Symptoms (iVMS)

Latest News

  1. CLASS ACTION NOTICE: Brodsky & Smith, LLC Reminds Investors of Deadline Regarding Investigation of Securities Violations
  2. FDX, ACER & DBD Class Action - Bronstein, Gewirtz & Grossman, LLC
  3. Zhang Investor Law Reminds Investors of August 30 Deadline in Securities Class Action Lawsuit Against Acer Therapeutics Inc. – ACER
  4. FDX, ACER & DBD Class Action Update and Upcoming Deadline - Bronstein, Gewirtz & Grossman, LLC
  5. IMPORTANT AUGUST DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  6. Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pivotal Software, Sunlands, Fred’s, and Acer Therapeutics and Encourages Investors to Contact the Firm
  7. SHAREHOLDER ALERT:  Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Acer Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – ACER
  8. FDX, ACER & DBD Class Action Reminder and Upcoming Deadline - Bronstein, Gewirtz & Grossman, LLC
  9. SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces Investigation of Securities Violations
  10. Acer Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
  11. DEADLINE APPROACHING: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against Acer Therapeutics, Inc.
  12. FDX, ACER & DBD Class Action and Upcoming Deadline - Bronstein, Gewirtz & Grossman, LLC
  13. UPCOMING DEADLINE REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Acer Therapeutics Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
  14. Factors Setting the Tone for Deere (DE) in Q3 Earnings
  15. CLASS ACTION DEADLINE: Brodsky & Smith, LLC Reminds Investors of Deadlines Regarding Investigation of Securities Violations
  16. Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eros International, Sunlands Technology, Fred’s, and Acer Therapeutics and Encourages Investors to Contact the Firm